Europe’s neurologists join forces in the European Academy of Neurology

Europe will now have just one international neurological association. The two European societies – the EFNS and the ENS – have merged during the Joint Congress of European Neurology in Istanbul to create the new European Academy of Neurology (EAN). Prof Günther Deuschl from Kiel, Germany, was elected the first President of the new organisation.

Günther Deuschl is Professor of Neurology and Chairman of the Department of...
Günther Deuschl is Professor of Neurology and Chairman of the Department of Neurology, Christian-Albrechts-Universität, Kiel

Günther Deuschl is Professor of Neurology and Chairman of the Department of Neurology, Christian-Albrechts-Universität, Kiel. His special interests include deep brain stimulation and tremor. „I am sure that this merger will move European neurology into a pole position”, the new EAN President said. "We want to stand together to fulfil the mission of this new society. It includes taking the lead in terms of neurological practice and education on this continent and defining standards of patient care in Europe, a region which is underway to harmonizing its health systems. This society also has a huge potential when it comes to promoting scientific progress in neurology and neurosciences in general.”

The General Assembly of the EAN also elected the following officers to serve on the board of the new organisation:

Vice President:
Prof Franz Fazekas, Graz, Austria

Secretary General:
Prof Didier Leys, Lille, France

Treasurer:
Prof Marianne de Visser, Amsterdam, The Netherlands

Chair Scientific Committee:
Prof Antonio Federico, Siena, Italy

Chair Liaison Committee:
Prof David Vodusek, Ljubljana, Slovenia

Member at large:
Prof Per Soelberg Sorensen, Kopenhagen, Denmark

The first EAN Congress is scheduled to take place in Berlin, Germany in June 2015.

04.06.2014

More on the subject:

Related articles

Photo

News • Neurodegenerative diseases

New biomarker improves diagnosis of Parkinson's and LBD

A biomarker discovered in the cerebrospinal fluid could improve diagnosis of Parkinson's disease and dementia with Lewy bodies.

Photo

News • Microscopic medicines

Intrabodies unlock new treatments for MND and Alzheimer's

New treatments for neurodegenerative diseases like Alzheimer’s, Parkinson’s, and motor neurone disease (MND) could be unlocked thanks to microscopic medicines called intrabodies.

Photo

News • Study explores 30-year trends

Multiple sclerosis: survival rates improve, but inequalities remain

People with multiple sclerosis (MS) now live significantly longer, thanks to advances in treatments and care, a new study finds. However, inequalities remain, with higher mortality in deprived areas.

Subscribe to Newsletter